Life support for critically ill patients
Conditions
Interventions
Experimental group/control group:Airway Assessment and Complication Pre-control Techniques in Severe Patients
Experimental group/control group:Removal of Retention on Balloon
Experimental group/control group:Evidence-based airway humidification and quantitative assessment techniques
Experimental group/control group:Assistant management of extracorporeal membrane oxygenation
Experimental group/control group:High frequency chest wall oscillation expectoration technique
Experimental group/control group:Vibrating screen atomization inhalation Technology
Experimental group/control group:Establishing effective vascular access is the lifeline for critically ill patients to be maintained
Experimental group/control group:Vascular access-related complications are key factors affecting the development of critical illness.
Experimental group/control group:Standardized and effective vascular access maintenance technology is an important link to improve the outcomes of critically ill patients
Experimental group/control group:Informatization monitoring system of early risk warning for critically ill patients
Experimental group/control group:Artificial intelligence pre-examination and triage
Experimental group/control group:Intramedullary Infusion
Experimental group/control group:Knowledge of early nutritional support
Sponsors
Shanghai Tenth People's Hospital
Eligibility
Sex/Gender
All
Age
14 Years to 90 Years
Inclusion criteria
Inclusion criteria: I. Airway management technology for critically ill patients: Inclusion criteria: Publication or update period is nearly 10 years; study subjects: adults, critically ill patients admitted to ICU; type of study: summary of evidence; clinical practice guidelines; systematic review. II. Pulmonary rehabilitation techniques for critically ill patients Inclusion criteria: 1. Age 15; oxygenation index (PaO2/FiO2 < 250 mmHg (1 mmHg = 0.133 Kpa); 3. Non-comatose patients who stayed in ICU for more than 14 days and were mechanically ventilated; 4. Exclude those with active bleeding stage and unfixed fracture; 5. Voluntary participation in this study, all patients and their families signed informed consent. III. Maintenance technology of vascular access in critically ill patients Inclusion criteria: 1. Patients with established vascular access, severe illness or possible changes at any time.Voluntary participation in this study, all patients and their families signed informed consent, and approved by the hospital ethics committee to implement the study. IV. Early life warning risk monitoring technology for critically ill patients Inclusion criteria: 1. Age < 18 years old; 2. Patients admitted to ICU; 3. Patients or family members agreed to participate in this study. V. Pre-control technology of factors affecting life support in critically ill patients 1. Research program for early identification of critically ill patients Inclusion criteria: (1) Age < 14 years 2. Research scheme of the application of intramedullary infusion technology in emergency treatment of critically ill patients Inclusion criteria: (1) Meet the diagnostic criteria for critical illness (including cardiac arrest, shock, trauma, etc.); (2) Patients or their family members volunteered to participate in the study and signed the informed consent. 3. Research scheme of nutritional support technology for critically ill patients Inclusion criteria: (1) All critically ill patients admitted from September 2020 to December 2021
Exclusion criteria
Exclusion criteria: I. Airway management technology for critically ill patients Exclusion criteria: Interventions: unrelated to subject matter; duplicate reporting; identical evidence of recommendation; incomplete data and unclear outcome effect. II. Pulmonary rehabilitation techniques for citically ill patients Exclusion criteria: 1. With severe aphasia, disturbance of consciousness, delirium, obvious mental abnormality, etc., the pulmonary rehabilitation training can not be completed; 2. There are other diseases that clearly lead to cognitive dysfunction, such as poliomyelitis, multiple sclerosis, spinal cord injury, Alzheimer's disease, etc. 3. There are other serious organic diseases: such as severe cardiopulmonary insufficiency, severe hepatic and renal insufficiency, severe infectious diseases, malignant tumors, severe trauma, etc. III. Maintenance technology of vascular access in critically ill patients Exclusion criteria: 1. Those with severe aphasia, disturbance of consciousness, delirium, obvious mental abnormality, etc., who cannot complete the cognitive assessment; there are other diseases that clearly lead to cognitive dysfunction. IV. Early life warning risk monitoring technology for critically ill patients Exclusion criteria: 1. Abandoned life support treatment V. Pre-control technology of factors affecting life support in critically ill patients 1. Research program for early identification of critically ill patients Exclusion criteria: Patients younger than 14 years of age, language communication disorders, deaf, mute and illiterate patients, withdrawn for personal reasons 2. Research scheme of the application of intramedullary infusion technology in emergency treatment of critically ill patients Exclusion criteria: (1) combined with osteomyelitis and open trauma at the puncture site of the bone marrow cavity; (2) Patients with heart, liver, kidney and other important organ dysfunction, malignant tumors, etc. 3. Research scheme of nutritional support technology for critically ill patients Exclusion criteria: nothing
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pulmonary infection score;Tracheal intubation catheter/tracheotomy catheter evaluation form;Sputum Viscosity Grading;Oxygenation index, duration of ventilator use;Total length of hospital stay, calculated as the time from the start of invasive ventilator use to ventilator evacuation;Time and complications from admission to discharge;At the patient level, risk factors associated with vascular access were reduced in critically ill patients;Incidence of vascular access-related complications in critically ill patients;Incidence of adverse events;patient outcomes;Grading accuracy and rejection rate;Success rate of one puncture;Adverse Reactions; | — |
Countries
China
Contacts
Public ContactXiaoping Zhu
Shanghai Tenth People's Hospital
Outcome results
None listed